logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jeremy D. Gale

Pfizer Inc
H指数:24
被引数:2,607

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of the interleukin-10–fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trial

白细胞介素-10–片段F8融合蛋白PF-06687234作为英夫利昔单抗加用疗法在活动性溃疡性结肠炎患者中的有效性与安全性：一项随机、IIa期临床试验

Therapeutic Advances in Gastroenterology
IF3.4
2026-02-100
PRE
Stefan Schreiber; Silvio Danese; Séverine Vermeire; Rupert W. Leong; Vivek Pradhan; Ravi Shankar P. Singh; Dahong Yu; Dean Messing; Hendrik Neubert; Joe Palandra; Christopher Tehlirian; Jeremy D. Gale
Clinical response trajectories identify distinct subpopulations of ulcerative colitis patients and are linked to disease outcome across different therapy classes. Patient level analysis of 2378 participants from 6 randomized controlled trials in moderate-severe UC representing 8 different mechanisms of action.
JOURNAL OF CROHNS & COLITIS
IF8.7
2025-01-220
PRE
Schreiber, S. W.; Mueller-Breckenridge, A.; Cheng, J.; Wu, C.; Jelinsky, S. A.; Liu, J.; Agueusop, I; Freitag-Wolf, S.; Hall, A.; Baribaud, F.; El Houjajji, C.; Paun, A.; Mcbride, J.; Branigan, P.; Hart, A.; Waterworth, D.; Gale, J.; Woolcott, J. C.; Flechsenhar, K.; Rawlings, C. A.; Candela, N.; Yajnik, V; Krawczak, M.; Thakker, P.; Hecht, P.
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study
LANCET RHEUMATOLOGY
IF16.4
2021-03-0122
PRE
Tehlirian, Christopher; Peeva, Elena; Kieras, Elizabeth; Scaramozza, Matthew; Roberts, Erika S.; Singh, Ravi Shankar P.; Pradhan, Vivek; Banerjee, Anindita; Garcet, Sandra; Xi, Li; Gale, Jeremy D.; Vincent, Michael S.; Krueger, James
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

30,931个体90种心血管蛋白的基因组及药物靶点评价

NATURE METABOLISM
IF20.8
2020-10-16354
OAAI
Folkersen, Lasse; Gustafsson, Stefan; Wang, Qin; Hansen, Daniel Hvidberg; Hedman, Asa K.; Schork, Andrew; Page, Karen; Zhernakova, Daria V.; Wu, Yang; Peters, James; Eriksson, Niclas; Bergen, Sarah E.; Boutin, Thibaud S.; Bretherick, Andrew D.; Enroth, Stefan; Kalnapenkis, Anette; Gadin, Jesper R.; Suur, Bianca E.; Chen, Yan; Matic, Ljubica; Gale, Jeremy D.; Lee, Julie; Zhang, Weidong; Quazi, Amira; Ala-Korpela, Mika; Choi, Seung Hoan; Claringbould, Annique; Danesh, John; Smith, George Davey; de Masi, Federico; Elmstahl, Solve; Engstrom, Gunnar; Fauman, Eric; Fernandez, Celine; Franke, Lude; Franks, Paul W.; Giedraitis, Vilmantas; Haley, Chris; Hamsten, Anders; Ingason, Andres; Johansson, Asa; Joshi, Peter K.; Lind, Lars; Lindgren, Cecilia M.; Lubitz, Steven; Palmer, Tom; Macdonald-Dunlop, Erin; Magnusson, Martin; Melander, Olle; Michaelsson, Karl; Morris, Andrew P.; Magi, Reedik; Nagle, Michael W.; Nilsson, Peter M.; Nilsson, Jan; Orho-Melander, Marju; Polasek, Ozren; Prins, Bram; Palsson, Erik; Qi, Ting; Sjogren, Marketa; Sundstrom, Johan; Surendran, Praveen; Vosa, Urmo; Werge, Thomas; Wernersson, Rasmus; Westra, Harm-Jan; Yang, Jian; Zhernakova, Alexandra; Arnlov, Johan; Fu, Jingyuan; Smith, J. Gustav; Esko, Tonu; Hayward, Caroline; Gyllensten, Ulf; Landen, Mikael; Siegbahn, Agneta; Wilson, James F.; Wallentin, Lars; Butterworth, Adam S.; Holmes, Michael V.; Ingelsson, Erik; Malarstig, Anders

研究方向

暂未获取到该数据
V
Vivek Pradhan
H 指数:15论文数:67被引数:763
E
Elena Peeva
H 指数:38论文数:203被引数:4,579
M
Michael S. Vincent
H 指数:37论文数:143被引数:4,098
A
Anindita Banerjee
H 指数:17论文数:39被引数:1,258
C
Christopher Tehlirian
H 指数:6论文数:21被引数:289
E
Emmanuel Tsochatzis
H 指数:76论文数:674被引数:3.2万
S
Silvio Danese
H 指数:139论文数:2,349被引数:8.8万
A
Asbjørn Mohr Drewes
H 指数:80论文数:1,151被引数:2.6万
J
Jarosław Leszczyszyn
H 指数:15论文数:44被引数:1,492
J
Jens Brøndum Frøkjær
H 指数:39论文数:394被引数:5,812